MedTrace Logo

Asymptomatic Bacteriuria Guideline Implementation Study

NCT01052545 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1598

Last updated 2019-02-25

Study results available
· View outcomes & findings →

Summary

Overtreatment of asymptomatic bacteriuria (ABU) is a quality, safety, and cost issue, particularly as unnecessary antibiotics lead to emergence of resistant pathogens. The investigators' proposal to bring clinical practice in line with published guidelines has significant potential to reduce unnecessary antibiotic use for ABU in the VA healthcare system, thus improving the quality and safety of veterans' healthcare. The investigators' study will also provide important insights about how to implement and sustain evidence-based clinical practice within VA hospitals.

Conditions

  • Infection Due to Indwelling Urinary Catheter
  • Asymptomatic Bacteriuria

Interventions

BEHAVIORAL

Audit-Feedback

Applied as a post-prescription antimicrobial review based on established guidelines.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Barbara Trautner, MD · Michael E. DeBakey VA Medical Center, Houston, TX

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01052545 on ClinicalTrials.gov